Piper Sandler Starts Coverage on BioAge Labs With Buy Rating and $73 Target
Piper Sandler initiates coverage of BioAge Labs with an Overweight rating, highlighting strong early data for its lead drug BGE-102 and key upcoming catalysts.
Piper Sandler initiates coverage of BioAge Labs with an Overweight rating, highlighting strong early data for its lead drug BGE-102 and key upcoming catalysts.
Deutsche Bank upgrades CoreWeave to Buy, sets a $140 price target, and highlights strong growth potential through 2026.
Cloudflare shares surge over 13% in pre-market trading as developers flock to use Cloudflare Tunnels for hosting Clawdbot, a viral AI assistant built on Claude's model.
The U.S. Army awarded Salesforce a $5.6 billion, 10-year contract to modernize outdated military systems using cloud technology and AI agents for faster decision-making and recruitment.
Needham upgrades Affirm to Buy with a $100 target, citing its plan to launch Affirm Bank as a potential growth and profitability catalyst.
Micron Technology announces $24B investment in Singapore over 10 years to expand NAND chip production amid AI-driven memory shortage affecting tech industry.